TRIB
Trinity Biotech
TRIB
TRIB
26 hedge funds and large institutions have $2.59M invested in Trinity Biotech in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
42% less capital invested
Capital invested by funds: $4.49M → $2.59M (-$1.9M)
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$38.6K | |
| 2 | +$13.9K | |
| 3 | +$9.45K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$8.17K |
| 5 |
Millennium Management
New York
|
+$6.63K |
Top Sellers
| 1 | -$57.6K | |
| 2 | -$45.8K | |
| 3 | -$16.5K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$12.2K |
| 5 |
Renaissance Technologies
New York
|
-$3.99K |